Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Iodine I 131 Monoclonal Antibody 3F8 for Brain Tumor
Recruiting1 awardPhase 2
New York, New York
This trial uses a monoclonal antibody that finds and attaches to tumor cells, and then kills them with a tumor-killing substance, without harming normal cells. Researchers want to see if this is an effective treatment for central nervous system cancer or leptomeningeal metastases, and what side effects it may cause.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.